We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 105.00 | 100.00 | 110.00 | 105.00 | 105.00 | 105.00 | 0.00 | 07:31:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.80 | 14M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2022 11:06 | Just a couple of omissions that I can see besides those mentioned by Yump. No development at Orissa (Odisha)and no mention of the Military. Veterinary is given a passing mention so I presume the contract is ongoing. £1.1m gone in six months, so plenty of cash for the foreseeable future. The creation and development of the CareLocker consumer app in conjunction with Sampurna Sodani Diagnostic Clinic in India is the most exciting part for me. Hopefully we will hear more about this in the New year. There's lots of high wealth individuals in India so if they are selling to the patients at the clinic, well who knows? Could be the start of a very lucrative pathway and seems a different direction from Bleepa. I see your frustration, Ducatiman but for me, although the progress is slow at least there is progress. Not yet the contracts that we all want so we have to wait a little longer. | ged5 | |
19/12/2022 10:39 | Let’s hope LR2 and hopefully the contracts will be ongoing. | ducatiman | |
19/12/2022 10:08 | Pretty sure he will Duc. Market cap - £11.4 mil. Cash - £9.2 mil. Company products value - £11.4 - £9.2 mil = £2.2 mil. Revenue for half year - £600k. Assume double for full year for now - £1.2 mil. Company products value less than 2 years income based on current figures. Sure the cash will diminish but the income will increase to replace it we hope. 2-3 more contracts are all that is required to get ahead of the cash burn. | lr2 | |
19/12/2022 09:56 | We’ve had jam tomorrow for years LR2! I reckon TO has 6 months to bring home the bacon. | ducatiman | |
19/12/2022 09:52 | Well, the company has potential. They mentioned it 4 times in the last 3 paragraphs. | lr2 | |
19/12/2022 07:59 | I still watch and wait, but sadly nobody appears to want to buy Bleepa. Talk talk with little buy buy is simply unsustainable. | davwal | |
19/12/2022 07:12 | Some reading! Let’s see. | ducatiman | |
13/12/2022 18:17 | Late reported buy trade - 13-Dec-22 15:11:06 88.00 14,474 £12,737.12 | lr2 | |
12/12/2022 20:37 | That was about April time from memory. Everything connected to Bleepa seems to start in April. | lr2 | |
12/12/2022 20:26 | I live in hope LR2 but the silence is worrying. When did the pilots in India start? | ducatiman | |
12/12/2022 20:19 | The people over on BIRD have been thinking like you Duc. Tomorrow they will be getting a Christmas bonus bright and early I suspect. Keep the faith. | lr2 | |
12/12/2022 20:13 | Well it doesn’t look like TO will be giving us shareholders a Christmas bonus, no doubt he will be getting one from us! | ducatiman | |
06/12/2022 15:53 | Keep walking Ged. Chart has resumed the downtrend amid some heavy selling today. Nothing short of disgraceful is Tom. | petekand | |
05/12/2022 11:20 | Well it went from 1v2 83v90 to 3v2 85v90 Can't stand the excitement so going for a walk! | ged5 | |
05/12/2022 10:23 | Agree with you, Yump, post 10435. There seems to be rumblings of work going on in the background but there has been a lack of news for too long now. Buying continuing again today. Perhaps traders seeing how oversold this is. | ged5 | |
03/12/2022 09:21 | Sorry, what was that ? I’d just dozed off ;-) | yump | |
03/12/2022 00:00 | I bet this will get a response from Yump. Take a road trip to discover true state of radiology. | lr2 | |
02/12/2022 11:34 | This is all about getting people to use a new system. It doesn’t matter how good or helpful it is, if its not compulsory, it will take ages. Bad enough introducing a new company system, where the decision has been made by the BOD and there’s no room for debate. In an NHS trust there is nobody to say “this will be used - end of”. Its always subject to 101 clinical opinions, despite it not really being a clinical issue. Anyway, I think shareholders now need to know, after all this time, exactly how many trusts are in discussions, together with the stage they are at. Just the numbers - no names needed. Been a long time since TO was supposedly doing the rounds and there are how many trusts ? An effing lot. I want to know if they’ve been actively selling, or just going to conferences and cosy meetings. And if not talking to them - why not ? Are they pursuing sonething else ? | yump | |
02/12/2022 11:14 | Ged5 - that "someone" most likely isn't sitting on a 70% loss like me and probably a few others here! | digger2779 | |
02/12/2022 10:06 | Another three trades this morning totaling 12500 shares. A couple yesterday afternoon. At least someone other than us thinks FDBK is worth an investment. | ged5 | |
01/12/2022 12:30 | “Future customers and partners” Nudge, nudge, wink, wink Guys! | ducatiman | |
01/12/2022 11:07 | I hadn't seen that Ged, nicely spotted. The bloke who posted 'See you in London, Tom', Scott Crawford, is from Barangaroo, New South Wales, Australia. Perhaps we are going to take off over there too. ____________________ Scott Crawford is a man with many talents. He has been a CEO for over 20 years, CEO and Founder of The Avante Group, and was a founder of Medical Imaging Partnership, is a Board Director of Detected X. Scott is also a strategic advisor to 23Strands and chairman of the board for Service Journal. | lr2 | |
01/12/2022 11:04 | To hell with the conferences - its not part of the NHS - no feebies to consultant conferences here thank you. Do it in your own time. | yump | |
01/12/2022 10:58 | Its not gone up yet? | ged5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions